Recall Record

Ambarnath, India

Rubicon Research Private Limited recalls

4 recalls recorded since 2018, most recently on 24 August 2024. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)3
Terminated or completed1
Class I (FDA)0

Ongoing Class III Drugs

Recall started
24 August 2024
Reason
Discoloration
Distribution
Nationwide in the US
Initiated
Voluntary: Firm initiated
Recall number
D-0659-2024

Ongoing Class II Drugs

Recall started
6 May 2024
Reason
Presence of Foreign Substance: metal in tablet
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0517-2024

Ongoing Class II Drugs

Recall started
26 April 2024
Reason
Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0487-2024

Terminated Class II Drugs

Recall started
31 December 2021
Terminated
4 November 2022
Reason
Complaint received of foreign matter (metal) embedded in tablet.
Distribution
Product was distributed to one distributor who may have distributed the product further nationwide.
Initiated
Voluntary: Firm initiated
Recall number
D-0362-2022

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.